Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice

Prothrombin Complex Concentrate (PCC) is a key treatment in the management of bleeding related to Vitamin K antagonists (VKA). This study aimed to evaluate prospectively PCC use in patients with VKA-related bleeding in view of the French guidelines published in 2008. All consecutive patients with VK...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Critical care (London, England) England), 2012-10, Vol.16 (5), p.R185-R185, Article R185
Hauptverfasser:	Desmettre, Thibaut, Dehours, Emilie, Samama, Charles-Marc, Jhundoo, Suchin, Pujeau, Frédéric, Guillaudin, Christian, Hecquart, Claudine, Clerson, Pierre, Crave, Jean Charles, Jaussaud, Roland
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Anticoagulants - pharmacology Anticoagulants - therapeutic use Blood Coagulation Factors - pharmacology Blood Coagulation Factors - therapeutic use Female France - epidemiology Hemorrhage - drug therapy Hemorrhage - epidemiology Hemorrhage - mortality Humans International Normalized Ratio Life Sciences Male Prospective Studies Survival Rate Treatment Outcome Vitamin K - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!